Professor Martin Yarmush was among 7 awardees of 190 applications solicited by the Harvard Institute of Translational Immunology of a one year $180,000 grant. Dr. Yarmush's project will take advantage of molecular biology and microfabrication techniques in order to detect autoantibody levels with great sensitivity. This achievement would enable the detection of the onset of Type 1 diabetes far earlier, allowing the use of interventions designed to deter disease progression.